Kellerhals Carrard advised Panakes Partners in leading the EUR 17.9 million Series B financing round of Lymphatica Medtech. This round was co-led by TechWald Holding S.p.A., and CDP Venture Capital SGR, with participation from
Kellerhals Carrard advised Panakes Partners in leading the EUR 17.9 million Series B financing round of Lymphatica Medtech. This round was co-led by TechWald Holding S.p.A., and CDP Venture Capital SGR, with participation from